Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cell Clinic Tokyo is a specialized medical facility located in the Ginza district of Tokyo, Japan, dedicated to regenerative medicine and advanced cellular therapies. Established in June 2024, the clinic offers a range of treatments including autologous adipose-derived mesenchymal stem cell (MSC) therapy, Natural Killer (NK) cell therapy, and exosome-based interventions. These services target various conditions such as chronic pain, metabolic disorders like diabetes, neurodegenerative diseases, and aesthetic concerns related to aging. The facility operates under the regulations of Japan's Act on the Safety of Regenerative Medicine and maintains a strategic partnership with CellBank for high-quality cell processing and cultivation. Led by Director Dr. Jun Tachibana, the clinic provides personalized, evidence-based care to both domestic and international patients seeking innovative solutions for health and longevity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell Clinic Tokyo.